Disease
Hypertension
Chronic elevation of arterial blood pressure (2017 ACC/AHA threshold: systolic >=130 or diastolic >=80 mmHg); the single largest modifiable driver of cardiovascular disease burden.
Coverage in progress. AssetMemo has not yet run its full census for Resistant Hypertension with Adducin/Ouabain Polymorphisms, so the assets listed for it are not complete.
Combined attributable cost
$347.4B+
Drug spend
$34.6B+
10% of total cost is drugs
Sum of 3 indications below.